Bevacizumab for Graft Rejection
Open Access
- 31 October 2007
- journal article
- other
- Published by Elsevier in Ophthalmology
- Vol. 114 (10) , 1950-1950.e1
- https://doi.org/10.1016/j.ophtha.2007.05.016
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular DegenerationAmerican Journal of Ophthalmology, 2006
- Regression of Iris Neovascularization After Intravitreal Injection of Bevacizumab in Patients With Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 2006
- Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyBiochemical and Biophysical Research Communications, 2005
- Outcomes of Repeat Penetrating Keratoplasty and Risk Factors for Graft FailureCornea, 2003
- Corneal neovascularizationCurrent Opinion in Opthalmology, 2001